Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
HHMI Bulletin
Currrent Issue Subscribe
Back Issues About the Bulletin
May '07
Features
divider
Cech
divider
Up Front
divider

Toward a Kinder,
Gentler Toxinsmall arrow


divider

More Than Skin Deep

divider

Big Lessons from
Small Brainssmall arrow


divider

Web Extra:
Putting the Brakes
on Cancersmall arrow


divider
Chronicle
divider
Perspectives
divider
Editor

Subscribe Free
Sign up now and receive the HHMI Bulletin by mail free.small arrow

UPFRONT: More Than Skin Deep

PAGE 2 OF 2

That realization led Fuchs and Mombaerts to wonder whether the skin stem cells they studied could be reprogrammed to generate other tissues. In the February 20, 2007, issue of the Proceedings of the National Academy of Sciences, the scientists reported the first successful cloning of healthy mice from adult stem cells. They achieved that goal by using the technique of nuclear transfer: replacing the nucleus of an unfertilized oocyte with the nucleus of an adult skin stem cell. After transfer to a mouse's uterus, such hybrid cells were capable of developing into healthy adult mice, showing that the adult skin stem-cell nuclei could be reprogrammed to produce all tissues in the adult mouse.

Mouse cloning from other somatic stem cells has been attempted before, but the few cloned mice that resulted were not normal and almost always died soon after birth. Fuchs' and Mombaerts' cloning experiments had success rates as high as 5.4 percent, and half of their cloned mice lived out normal life spans.

I felt that if you want to understand the basis of human diseases, you need to understand what's normal before you can attempt to understand what's abnormal. —Elaine Fuchs

Instead of introducing a mouse hybrid embryo into a mother to produce a cloned offspring, Fuchs points out, the embryo could be grown in a culture dish with the goal of producing embryonic stem cells. If scientists are able to adapt this strategy to human skin stem cells, she says, this technology might prove to be clinically important in the future. "You might then be able to tailor-make embryonic stem cells to a particular patient and thereby avoid rejection by the immune system," she says. "Additionally, you might be able to study a patient's neurodegenerative disease by creating neurons from the embryonic stem cells generated from a skin biopsy."

Does Fuchs still do crossword puzzles as a diversion? She says they no longer interest her. "What I used to like about crossword puzzles is that you knew when you had solved the problem. In biology, you can never solve the problem. But that's what I now find fascinating. With the results of each new experiment comes the next question to address." grey bullet

dividers
PAGE 2 OF 2
small arrow Back
dividers
Download Story PDF
Requires Adobe Acrobat
Email This Story

HHMI INVESTIGATOR

Elaine Fuchs
Elaine Fuchs
 
Related Links

AT HHMI

bullet icon

Mice Cloned from Skin Cells
(02.12.07)

bullet icon

Researchers Identify a Key Regulator for Skim Stem Cells
(10.06.06)

bullet icon

Key Molecule Puts Brakes on Stem-Cell Differentiation
(06.30.06)

bullet icon

BioInteractive: Somatic Cell Nuclear Transformation animation and video

ON THE WEB

external link icon

NIH: Stem Cell Information

external link icon

Skin Anatomy

dividers
Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2012 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org